Patient education
CDI, HA-CDI
Patients included in Prevent CDI-55 + received a patient information package upon probiotic administration containing a brochure illustrating the initiative, the use of probiotics, and its effectiveness in preventing HA-CDI. Additionally, the package included information and findings from clinical studies on the effectiveness and safety of Bio-K + ® probiotics as an option for probiotic use, along with information about which local pharmacies carried Bio-K + ®.All printed material provided in the patient information package was reviewed and approved by three CDI patients, a pharmacy sub-committee, AHS Communications, and the AHS Engagement and Patient Experience committee before the initial implementation start date.